North America Immunotherapy Drugs Market by drug type (monoclonal antibodies, interferons, interleukins, vaccines and checkpoint inhibitors), by application (Blood Cancer, Cervical Cancer, Breast Cancer, Glioblastoma, Lung Cancer, Gastric Cancer, Prostate Cancer and Melanoma) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

North America Immunotherapy Drugs Market by drug type (monoclonal antibodies, interferons, interleukins, vaccines and checkpoint inhibitors), by application (Blood Cancer, Cervical Cancer, Breast Cancer, Glioblastoma, Lung Cancer, Gastric Cancer, Prostate Cancer and Melanoma) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1157 | Pages: 131 | November 2016 | Region: North America


North America Immunotherapy Drugs Market is accounted for USD 35.37 billion in 2016 and is estimated to reach USD 57.54 billion by 2021 with a cumulative annual growth rate (CAGR) of 10.1%. With the rising incidences of cancer cases and autoimmune diseases, there has been an increasing demand of immunotherapy drugs and is likely to have a positive outlook for its market in the forecast period.

Immunotherapy is a type of treatment for cancer which enhances the immune system to fight against cancer. Immunotherapies either stimulates the activity done by a particular component of the immune system or counteract the immune system produced by the cancer cells suppressing the immune responses.

With the evolution of innovation and technology, increasing prevalence of cancer and auto immune diseases, immunotherapy drugs are expected to gain significance in the future. Some other driving factors for the immunotherapy drugs includes rising incidences of diseases, higher efficiency than the common drugs, acceleration in the development and review of new drugs. However, the market is dampened by the high costs involving immunotherapy drugs and limited access to the lower and middle-income groups.

North American market for Immunotherapy Drugs is categorised on the basis of type of drugs and application. On the basis of type of drugs, the market is classified into monoclonal antibodies, interleukins, interferons, checkpoint inhibitors and vaccines. Based on application, the market is divided as Blood Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Cervical Cancer, Glioblastoma and Melanoma. Based on geography, the market is segmented into USA and Canada.

North America is currently the leading market with majority of the share and is likely to sustain in the review period. This is the attributed the higher incidences of cancer and infectious diseases coupled with high affordability and well-structured reimbursement plans. On the basis of geography, North American market is categorised as United States and Canada.

The major manufactures of Immunotherapy drugs includes Roche, Merck, Eli Lilly, Novartis, AstraZeneca, GlaxoSmithKline PLC, Amgen, Celgene, Bristol Myers Squibb and Seattle Genetics.

1. Introduction                 

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Research Phases      

                                2.2.1 Secondary Research

                                2.2.2 Primary Research

                                2.2.3 Econometric Modelling

                                2.2.4 Expert Validation

                2.3 Analysis Design         

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 By Drug Type             

                                5.1.1 Monoclonal Antibodies

                                5.1.2 Interferons

                                5.1.3 Interleukins

                                5.1.4 Vaccines

                                5.1.5 Checkpoint Inhibitors

                5.2 By Application           

                                5.2.1 Blood Cancer

                                5.2.2 Cervical Cancer

                                5.2.3 Breast Cancer

                                5.2.4 Glioblastoma

                                5.2.5 Lung Cancer

                                5.2.6 Gastric Cancer

                                5.2.7 Prostate Cancer

                                5.2.8 Melanoma

6. Geographical Analysis                              

                6.1 Introduction              

                6.2 United States            

                6.3 Canada         

7. Pipeline Product Analysis                        

                7.1 Overview                    

                7.2 Pipeline Development Landscape                     

                7.3 Molecular Targets in the Pipeline                     

                7.4 Clinical Trials              

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target 

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.

8. Strategic Analysis                       

                8.1 PESTLE analysis         

                                8.1.1 Political

                                8.1.2 Economic

                                8.1.3 Social

                                8.1.4 Technological

                                8.1.5 Legal

                                8.1.6 Environmental

                8.2 Porter’s Five analysis              

                                8.2.1 Bargaining Power of Suppliers

                                8.2.2 Bargaining Power of Consumers

                                8.2.3 Threat of New Entrants

                                8.2.4 Threat of Substitute Products and Services

                                8.2.5 Competitive Rivalry within the Industry

9. Market Leaders' Analysis                        

                9.1 Eli Lilly           

                                9.1.1 Overview

                                9.1.2 Product Analysis

                                9.1.3 Financial analysis

                                9.1.4 Recent Developments

                                9.1.5 SWOT analysis

                                9.1.6 Analyst View

                9.2 Merck           

                9.3 Roche           

                9.4 Amgen         

                9.5 Novartis       

                9.6 Celgene       

                9.7 AstraZeneca

                9.8 Bristol Myers Squibb              

                9.9 GlaxoSmithKline PLC              

                9.10 Seattle Genetics    

10. Competitive Landscape                         

                10.1 Market share analysis          

                10.2 Merger and Acquisition Analysis     

                10.3 Agreements, collaborations and Joint Ventures       

                10.4 New Product Launches       

11. Market Outlook and Investment Opportunities                          

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Immunotherapy Drugs Market By Region, From 2016-2021 (USD Billion)
  2. North America Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  3. North America Monoclonal Antibodies Market By Region, From 2016-2021 (USD Billion)
  4. North America Interferons Market By Region, From 2016-2021 (USD Billion)
  5. North America Interleukins Market By Region, From 2016-2021 (USD Billion)
  6. North America Vaccines Market By Region, From 2016-2021 (USD Billion)
  7. North America Checkpoint Inhibitors Market By Region, From 2016-2021 (USD Billion)
  8. North America Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  9. North America Blood Cancer Market By Region, From 2016-2021 (USD Billion)
  10. North America Cervical Cancer Market By Region, From 2016-2021 (USD Billion)
  11. North America Breast Cancer Market By Region, From 2016-2021 (USD Billion)
  12. North America Glioblastoma Market By Region, From 2016-2021 (USD Billion)
  13. North America Lung Cancer Market By Region, From 2016-2021 (USD Billion)
  14. North America Gastric Cancer Market By Region, From 2016-2021 (USD Billion)
  15. North America Prostate Cancer Market By Region, From 2016-2021 (USD Billion)
  16. North America Melanoma Market By Region, From 2016-2021 (USD Billion)
  17. United States Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  18. United States Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
  19. Canada Immunotherapy Drugs Market By Drug Type, From 2016-2021 (USD Billion)
  20. Canada Immunotherapy Drugs Market By Application, From 2016-2021 (USD Billion)
North America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncolog...
Middle East And Africa High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application...
Latin America High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncolog...
Europe High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glau...
Asia Pacific High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology...
High Potency Active Pharmaceutical Ingredients Market By Type (Innovative HPAPI’s And Generic HPAPI’s), By Synthesis (Biotech HPAPI’s And Synthetic HPAPI’s), By Therapeutic Application (Oncology, Glaucoma, H...
North America Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screen...
Middle East And Africa Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pestici...
Latin America Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screen...
Europe Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screening, Ge...
Asia Pacific Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screeni...
Global Cannabis Testing Market By Product & Software (Analytical Instruments, Consumables And Software), By Testing Procedures (Terpene Profiling, Potency Testing, Residual Solvent Screening, Pesticide Screening, Ge...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.